Center for Rare Tumors
One in five people with cancer is a rare species. Rare cancers are often recognized late. As a result, people sometimes receive a diagnosis (too) late. As a result, the chance of survival for patients with a rare form of cancer is still many times smaller than for patients with a non-rare form of cancer.
National centres of expertise for rare diseases
Little specific research is done on rare forms of cancer. As a result, few effective treatment methods and new medicines become available for these patients. At the Netherlands Cancer Institute, we use a special DNA test: the Whole Genome Sequencing (WGS) test. In this test, we read the entire DNA of the tumor. This is essential for making the correct diagnosis and for the best tailor-made treatment.
In order to be able to offer better, integrated care to patients, it is necessary to bundle knowledge about these rare cancers. The Netherlands Cancer Institute is a nationally and internationally leading centre of expertise for rare cancers with an excellent treatment team. The team provides personalized patient care and combines this with conducting groundbreaking research. In this way, we want to improve survival and quality of life for patients now and in the future.
The Netherlands Cancer Institute has twelve centres of expertise that are recognised by the Ministry of Health, Welfare and Sport/NFU. Various conditions can fall within one centre of expertise (for example, the Urology centre of expertise includes the rare tumours penile cancer and testicular cancer).
- Sarcoma Expertise Centres:
 Soft tissue sarcomas
 Gastrointestinal stromal cell tumor (GIST)
- Expert Center of Neuroendocrine Carcinomas together with UMC Utrecht.
- Expert centre for rare urological diseases:
 Testicular cancer
 Penile cancer
- Center of Rare Head and Neck Tummours:
 Nasopharyngeal carcinoma
 Laryngeal carcinoma (laryngeal cancer)
 Salivary gland tumors
- Expert Center for Hereditary Cancer
 Hereditary breast cancer
 Hereditary ovarian cancer
 Hereditary Diffuse Gastric Cancer
 (Attenuated) Familial Adenomatous Polyposis
 Hereditary Mixed Polyposis Syndrome
 Lynch Syndrome
 Serrated polyposis syndrome
- Expertise center for Li-Fraumeni syndrome (in collaboration with the Princess Máxima Center in Utrecht)
- Rare Skin Cancer Center:
 Merkel cell carcinoma
- Centre for rare nervous system tumours
- Centre of expertise for rare gynaecological tumours. In collaboration with Amsterdam UMC within the Center for Gynaecological Oncology Amsterdam, CGOA.
 Ovarian cancer (ovarian cancer)
 Vulvar/vaginal carcinoma
 Rare tumors of corpus uteri (uterine cancer)
 Cervical cancer
 Trophoblastic diseases ((Pre)malignant abnormalities from the placenta)
- Mesothelioma Expert Center of rare thoracic tumours – pleural mesothelioma.
- Expert Center for thyroid neoplasm
 Thyroid carcinoma
- Center for rare anal cancer and rare GI tumors (Netherlands Cancer Institute - Center of rare anal cancer and GI tumors) – Anus carcinoma and rare gastrointestinal tumors
 
        Rare cancers: sharing expertise and national collaboration
European recognitions
ERN EURACAN: EUropean RAre CANcers – Reference Network for Rare Solid Cancers in Adults
In addition to the Dutch recognition, we participate in the European reference networks for rare cancers in adults. European Reference Networks (ERNs) are virtual networks of healthcare providers in Europe. They have set themselves the goal of tackling complex or rare diseases and conditions that require highly specialised treatments and concentrated knowledge and resources.
- Sarcoma Expertise Centres
- Expert centre for rare urological diseases
- Expert Center of Neuroendocrine Carcinomas
- Center of Expertise for Rare Gynaecological Tumors (Center Gynaecologic Oncology Amsterdam)
- Center of Rare Head and Neck Tumours
- Expert Center of rare thoracic tumours
ERN EUROGEN
Sub-Thematic areas of expertise:
- Penile carcinoma
- Testicular carcinoma
ERN GENTURIS
Sub-thematic areas of expertise:
- Lynch syndrome
- Polyposis
- Hereditary breast
- Ovarian cancer
 
         nl
            nl
         
         
        